All questions
Question 1
An enzyme in glycogen breakdown is tested in vitro. Adding AMP increases activity at low substrate, consistent with a left-shifted sigmoidal curve, while Vmax is similar. Which physiological condition would most likely mimic the effect of AMP on this enzyme?
- Increased membrane glucose transport causing higher extracellular glucose
- High ATP and high citrate indicating abundant energy
- High NADH/NAD+ ratio indicating reduced electron transport
- Low cellular energy charge with elevated AMP relative to ATP (correct answer)
Explanation: This question examines physiological regulation mimicking allosteric effects in enzyme kinetics, focusing on energy status. Allosteric activators like AMP shift sigmoidal curves left, increasing activity at low substrate without changing Vmax, signaling low energy to promote catabolism. For the glycogen breakdown enzyme, AMP enhances low-substrate activity with similar Vmax, akin to low energy conditions. Answer D fits as elevated AMP in low energy charge would activate similarly, promoting glycogenolysis. Distractor B, high ATP/citrate, is incorrect as it inhibits catabolic enzymes, opposing activation. In similar queries, link effectors to cellular states; AMP indicates energy need. This integrates kinetics with metabolism.
Question 2
A lab compares an enzyme's kinetics in two buffers (both pH 7.4, 37°C) for a glycolytic enzyme. Buffer A contains 1 mM Mg2+; Buffer B contains 10 mM EDTA. In Buffer B, Vmax decreases markedly while apparent Km is similar. Which condition would most likely increase enzyme activity back toward Buffer A levels?
- Increase pH to deprotonate EDTA and reduce its affinity
- Add more substrate to overcome competitive inhibition by EDTA
- Decrease enzyme concentration to reduce EDTA binding
- Add Mg2+ in excess to overcome chelation and restore catalysis (correct answer)
Explanation: This question examines cofactor dependency and inhibition in enzyme kinetics and regulation, specifically chelation effects. EDTA chelates metal ions like Mg2+, essential for some enzymes, reducing active enzyme fraction and thus Vmax, with Km often unchanged akin to noncompetitive inhibition. In the glycolytic enzyme comparison, Buffer B with EDTA lowers Vmax while Km remains similar, likely due to Mg2+ removal. Answer D is fitting because excess Mg2+ would saturate despite EDTA, restoring cofactor availability and catalysis. Distractor B, adding substrate, is incorrect as it addresses competitive inhibition, not cofactor depletion. In related questions, identify if metals are involved; chelators suggest cofactor issues resolvable by ion addition. Consider assay conditions: buffers can inadvertently inhibit via ion sequestration.
Question 3
An enzyme in gluconeogenesis was tested with a small molecule that binds only to the free enzyme (not ES). The inhibitor increases the substrate concentration needed to reach v0=0.5Vmax, but the same maximal velocity is reached at saturating substrate. Which inhibition pattern is most consistent with this behavior?
- Competitive inhibition (correct answer)
- Uncompetitive inhibition
- Noncompetitive inhibition
- Product inhibition that increases Vmax
Explanation: This question examines inhibition mechanisms in enzyme kinetics and regulation, focusing on binding specificity. Competitive inhibitors bind only free enzyme, increasing apparent Km by reducing available active sites, but Vmax is achievable at high substrate. For the gluconeogenesis enzyme, the molecule binds only free enzyme, raising half-maximal substrate but allowing same Vmax at saturation. Answer A is consistent as this binding and kinetic pattern define competitive inhibition. Distractor B, uncompetitive, is wrong because it binds ES and decreases Km, opposing the increased Km observed. For related queries, note binding preference: free E suggests competitive. This distinguishes from inhibitors binding ES or both.
Question 4
An enzyme in the urea cycle is assayed at constant [substrate]. When a second molecule (effector E) is added, the initial rate increases immediately, with no change in enzyme concentration. Which mechanism most directly explains this rapid increase in activity?
- Allosteric activation that increases catalytic efficiency or substrate affinity (correct answer)
- Increased transcription of the enzyme gene leading to higher Vmax
- Increased translation of the enzyme mRNA leading to more enzyme molecules
- Decreased substrate transport into the reaction vessel
Explanation: This question assesses rapid regulatory mechanisms in enzyme kinetics, distinguishing allosteric from genomic effects. Allosteric activation binds and immediately enhances enzyme activity by increasing affinity or efficiency, without changing enzyme amount. In the urea cycle enzyme assay, effector E promptly raises rate at constant substrate and enzyme, indicating direct modulation. Answer A is correct as the immediate increase suggests allosteric enhancement of catalysis or affinity. Distractor B, increased transcription, is wrong for in vitro rapid change, confusing long-term regulation. For similar questions, note timescale: immediate effects are allosteric or post-translational. This differentiates from slower gene expression changes.
Question 5
A researcher studies an enzyme with two substrates, A and B, but runs assays with B saturating. Inhibitor N decreases Vmax and leaves apparent Km for A unchanged. Based on the scenario, what effect does inhibitor N have on enzyme function with respect to A?
- Competitive inhibition versus A
- Noncompetitive inhibition versus A (correct answer)
- Competitive inhibition versus B (therefore Km for A must increase)
- Uncompetitive inhibition versus A (therefore Km for A must decrease)
Explanation: This question evaluates inhibition classification in bisubstrate enzyme kinetics and regulation. Noncompetitive inhibition versus a substrate decreases Vmax without altering its Km, as the inhibitor binds independently, often at allosteric sites. With B saturating, inhibitor N lowers Vmax but keeps Km for A unchanged, indicating noncompetitive relative to A. Answer B fits because the kinetics show independent effects on catalysis, not affinity for A. Distractor A, competitive versus A, is incorrect as it would increase Km for A, missing the unchanged Km. In like problems, saturate one substrate to isolate effects on the other. This reveals if inhibition is specific or general.
Question 6
An uncompetitive inhibitor halves apparent Km and Vmax. How does the Lineweaver-Burk slope change?
- Stays the same (correct answer)
- Increases 2-fold
- Decreases 2-fold
- Increases 4-fold
Explanation: Uncompetitive inhibition divides both apparent Km and Vmax by the same factor. The Lineweaver-Burk slope is Km/Vmax, so (Km/2)/(Vmax/2) = Km/Vmax, unchanged. The tempting error is thinking only Vmax decreases, which would double the slope.
Question 7
An enzyme remains activated after extensive dialysis. Which mechanism most likely explains it?
- Allosteric activation
- Feedback inhibition
- Competitive inhibition
- Covalent phosphorylation (correct answer)
Explanation: Dialysis removes small molecules and noncovalent ligands, but covalent modifications stay attached. Covalent phosphorylation is a permanent enzyme modification that survives dialysis, keeping the enzyme active. The tempting wrong answer is allosteric activation, which relies on a reversibly bound activator that dialysis would wash away.
Question 8
At 0.8 mM substrate, v = 0.5 Vmax. What [S] gives v = 0.9 Vmax?
- 0.9 mM
- 3.6 mM
- 7.2 mM (correct answer)
- 8.0 mM
Explanation: At half Vmax, [S] equals Km, so Km is 0.8 mM. For v = 0.9 Vmax, solve 0.9 = [S] / (0.8 + [S]), which gives [S] = 9 Km = 7.2 mM. The tempting 0.9 mM choice just matches v/Vmax numerically, but substrate concentration is not equal to velocity.
Question 9
A regulator binds outside the active site and raises apparent Km with Vmax unchanged. Best classification?
- Competitive inhibition
- Allosteric inhibition (correct answer)
- Noncompetitive inhibition
- Irreversible inhibition
Explanation: A regulator that binds away from the active site is by definition allosteric. Even though raising apparent Km while leaving Vmax unchanged looks like classic competitive kinetics, that pattern identifies the kinetic effect, not the binding site. The tempting wrong answer is competitive inhibition, but competitive inhibitors must bind at the active site, which the question rules out.
Question 10
A noncompetitive inhibitor halves Vmax without changing Km. At [S]=2Km, what fraction of uninhibited velocity is seen?
- 0.33
- 0.50 (correct answer)
- 0.67
- 1.00
Explanation: At [S]=2Km, the uninhibited velocity is (2/3)Vmax. A noncompetitive inhibitor lowers Vmax to half, giving inhibited velocity (1/2)(2/3)Vmax = (1/3)Vmax. Dividing by uninhibited (2/3)Vmax gives 1/2. The tempting 0.67 is the uninhibited velocity itself, not the fraction after inhibition.
Question 11
A lab studies acetylcholinesterase (AChE) kinetics at 25°C in buffer (pH 7.0). With no inhibitor, Vmax=120 μM/min and Km=50 μM for acetylthiocholine. With 10 nM compound X, Vmax remains 120 μM/min but apparent Km increases to 200 μM. Based on these results, what effect does compound X have on AChE function?
- Uncompetitive inhibition that decreases both apparent Km and Vmax
- Competitive inhibition that increases apparent Km without changing Vmax (correct answer)
- Noncompetitive inhibition that decreases Vmax without changing apparent Km
- Allosteric activation that decreases apparent Km and increases Vmax
Explanation: This question tests recognition of competitive inhibition patterns in enzyme kinetics. Competitive inhibitors compete with substrate for the active site, which can be overcome by increasing substrate concentration, thus leaving Vmax unchanged while increasing the apparent Km. The data shows compound X causes a 4-fold increase in apparent Km (from 50 to 200 μM) while Vmax remains at 120 μM/min, which is the classic signature of competitive inhibition. The correct answer B accurately identifies this pattern, while option C incorrectly suggests noncompetitive inhibition would leave Km unchanged, when noncompetitive inhibitors actually decrease Vmax without affecting Km. To identify competitive inhibition, check if only Km increases while Vmax stays constant - this indicates the inhibitor can be outcompeted by excess substrate.
Question 12
A cytosolic enzyme in the pentose phosphate pathway is tested at 37°C. Under baseline conditions, the enzyme displays a hyperbolic v vs. [S] curve. After adding a regulatory protein Z, the v vs. [S] relationship becomes sigmoidal, but the maximal rate at very high substrate concentration is similar to baseline. Which mechanism is most consistent with protein Z's effect?
- Reduced substrate diffusion that lowers apparent Km and increases Vmax
- Irreversible active-site modification that reduces Vmax at all substrate concentrations
- Competitive inhibition that increases apparent Km while maintaining a hyperbolic curve
- Induction of cooperative substrate binding through allosteric regulation (correct answer)
Explanation: This question tests recognition of cooperative binding induced by allosteric regulation. The transition from a hyperbolic to sigmoidal velocity versus substrate curve is the hallmark of positive cooperativity, where binding of substrate to one site increases affinity at other sites. Protein Z acts as an allosteric regulator that induces cooperative substrate binding, changing the enzyme from Michaelis-Menten to sigmoidal kinetics while maintaining similar maximal velocity at saturating substrate. The correct answer D identifies this as induction of cooperativity through allosteric regulation, while option C incorrectly suggests competitive inhibition would maintain a hyperbolic curve shape. To identify cooperative binding, look for the characteristic S-shaped (sigmoidal) curve that replaces the typical hyperbolic Michaelis-Menten curve, indicating multiple substrate binding events influence each other.
Question 13
Investigators measured initial velocities of purified human phosphofructokinase-1 (PFK-1) at 37°C, pH 7.4, with saturating ATP (5 mM) and varying fructose-6-phosphate (F6P). In the presence of 2 mM citrate, the apparent K0.5 for F6P increased, while Vmax was unchanged. Which interpretation best describes citrate's effect on PFK-1 under these conditions?
- Citrate acts as an allosteric inhibitor that decreases apparent substrate affinity without changing catalytic capacity (correct answer)
- Citrate acts as a competitive inhibitor at the active site that decreases Vmax but not apparent Km
- Citrate acts as a noncompetitive inhibitor that decreases both apparent Km and Vmax
- Citrate increases PFK-1 activity by stabilizing the high-affinity (R) state, lowering apparent K0.5
Explanation: This question tests understanding of allosteric regulation in enzyme kinetics, specifically how citrate affects phosphofructokinase-1 (PFK-1). Allosteric inhibitors bind at sites distinct from the active site and can alter enzyme affinity for substrate without affecting the maximum catalytic capacity. In this experiment, citrate increases the apparent K₀.₅ (the substrate concentration at half-maximal velocity for allosteric enzymes) while leaving Vmax unchanged, which is characteristic of K-type allosteric inhibition that decreases substrate affinity. The correct answer A accurately describes this mechanism, while option B incorrectly suggests competitive inhibition would decrease Vmax, which contradicts the fundamental property that competitive inhibitors only affect Km. To identify allosteric K-type inhibition, look for increased K₀.₅ or Km with unchanged Vmax, indicating the inhibitor makes substrate binding less favorable without affecting the enzyme's catalytic capacity when saturated.
Question 14
An enzyme is assayed at 25°C with [S]=Km. Under baseline conditions, the initial velocity is 50% of Vmax. A reversible inhibitor is added that decreases Vmax by 50% while leaving Km unchanged. At the same substrate concentration ([S]=Km), what happens to the initial velocity relative to the original Vmax?
- It becomes 100% of the original Vmax because Km is unchanged
- It remains 50% of the original Vmax
- It becomes 75% of the original Vmax
- It becomes 25% of the original Vmax (correct answer)
Explanation: This question tests mathematical understanding of enzyme kinetics under noncompetitive inhibition. At [S] = Km, the initial velocity equals Vmax/2 under normal conditions according to the Michaelis-Menten equation. When a noncompetitive inhibitor reduces Vmax by 50% (to 0.5 × original Vmax) without changing Km, the new velocity at [S] = Km becomes (0.5 × Vmax)/2 = 0.25 × original Vmax. The correct answer D shows this calculation: 25% of original Vmax, while option B incorrectly assumes the velocity remains at 50% because it confuses the fraction of the new Vmax with the fraction of the original Vmax. For noncompetitive inhibition problems, remember that the velocity at any substrate concentration is reduced by the same factor as Vmax is reduced.
Question 15
A liver enzyme in gluconeogenesis is regulated by phosphorylation. In hepatocytes exposed acutely (10 min) to glucagon, the enzyme's Vmax increases with no change in Km for its substrate. Which mechanism best explains the kinetic change observed after glucagon treatment?
- Covalent modification increases catalytic turnover (kcat) without altering substrate binding affinity (correct answer)
- Competitive inhibition is relieved, decreasing Km and increasing Vmax
- Increased substrate transport into hepatocytes lowers apparent Km without affecting Vmax
- Gene transcription increases enzyme concentration, primarily decreasing Km within 10 minutes
Explanation: This question tests understanding of covalent modification as a rapid enzyme regulation mechanism. Glucagon triggers a signaling cascade that phosphorylates key gluconeogenic enzymes within minutes, a timeframe too short for significant changes in gene expression or protein synthesis. The observation that Vmax increases without Km change indicates the phosphorylation increases the catalytic efficiency (kcat) of existing enzyme molecules without altering their substrate binding affinity. The correct answer A correctly identifies this as increased catalytic turnover through covalent modification, while option D incorrectly suggests gene transcription could occur within 10 minutes, when transcription and translation typically require hours. For rapid enzyme regulation (minutes), look for covalent modifications like phosphorylation that alter catalytic efficiency, not changes in enzyme concentration.
Question 16
In a reconstituted glycolysis system, pyruvate kinase (PK) activity is measured at 37°C with saturating phosphoenolpyruvate. When 2 mM alanine is added, the initial rate decreases at all tested ADP concentrations, and increasing ADP does not restore the original maximal rate. Which condition would most likely increase PK activity in the presence of alanine?
- Addition of fructose-1,6-bisphosphate as an allosteric activator (correct answer)
- Further increasing alanine concentration to shift equilibrium toward product formation
- Decreasing pH to protonate alanine and enhance inhibitory binding
- Lowering phosphoenolpyruvate to reduce substrate saturation and overcome inhibition
Explanation: This question tests understanding of allosteric regulation in metabolic enzymes, specifically pyruvate kinase regulation. Alanine acts as an allosteric inhibitor of pyruvate kinase that cannot be overcome by increasing substrate (ADP) concentration, indicating it reduces enzyme activity through conformational changes rather than active site competition. Fructose-1,6-bisphosphate (F-1,6-BP) is a well-known allosteric activator of pyruvate kinase that can counteract inhibition by stabilizing the active conformation. The correct answer A identifies F-1,6-BP as an allosteric activator that would increase activity, while option B incorrectly suggests increasing inhibitor concentration would help. To overcome allosteric inhibition, add an allosteric activator that stabilizes the active enzyme conformation, not more substrate or inhibitor.
Question 17
A kinase is assayed at 30°C with saturating ATP (2 mM). The enzyme follows Michaelis–Menten kinetics for peptide substrate S with Km=10 μM and Vmax=80 nmol/min. A reversible inhibitor Y binds only to the enzyme–substrate complex (ES). Which change is most consistent with adding inhibitor Y at a fixed concentration?
- Increased apparent Km and increased Vmax
- Increased apparent Km and unchanged Vmax
- Unchanged apparent Km and decreased Vmax
- Decreased apparent Km and decreased Vmax (correct answer)
Explanation: This question tests understanding of uncompetitive inhibition, a less common but important inhibition pattern. Uncompetitive inhibitors bind only to the enzyme-substrate complex (ES), not to free enzyme, which uniquely decreases both apparent Km and Vmax proportionally. Since inhibitor Y specifically binds to the ES complex, it will stabilize this complex, effectively removing it from the catalytic cycle, which reduces the apparent Km (by depleting free enzyme) and decreases Vmax (by reducing productive ES turnover). The correct answer D accurately predicts both parameters decrease, while option B incorrectly suggests only Km would increase, which is characteristic of competitive rather than uncompetitive inhibition. To identify uncompetitive inhibition, remember that both Km and Vmax decrease by the same factor, creating parallel lines on a Lineweaver-Burk plot.
Question 18
A bacterial enzyme required for folate synthesis is tested with substrate PABA at 37°C. Sulfonamide drug S is added and the measured kinetics show increased apparent Km for PABA with no change in Vmax. Which experimental change would most likely restore the reaction rate at a fixed inhibitor concentration?
- Add more inhibitor to shift binding toward the enzyme–inhibitor complex
- Decrease enzyme concentration to reduce inhibitor binding sites
- Increase PABA concentration substantially above Km (correct answer)
- Lower temperature to increase collision frequency and overcome inhibition
Explanation: This question tests understanding of competitive inhibition and strategies to overcome it. Sulfonamide drugs are classic competitive inhibitors of bacterial folate synthesis enzymes, competing with PABA for the active site, which explains the increased apparent Km with unchanged Vmax. Since competitive inhibition can be overcome by increasing substrate concentration, substantially increasing PABA above Km will outcompete the inhibitor and restore reaction rates. The correct answer C identifies this strategy of increasing substrate concentration, while option B incorrectly suggests decreasing enzyme concentration would help, when this would actually reduce the reaction rate further. To overcome competitive inhibition at fixed inhibitor concentration, increase substrate concentration well above Km to outcompete the inhibitor for active site binding.
Question 19
A bacterial enzyme in the shikimate pathway is feedback-regulated by the end product Z binding an allosteric site. In vitro, adding Z shifts the v0 vs [substrate] curve to the right and makes it more sigmoidal, but the maximal rate at very high [substrate] is approximately unchanged. Which condition would most likely increase enzyme activity in the presence of Z?
- Lowering temperature to increase collision frequency and raise Vmax
- Decreasing substrate concentration to reduce binding of Z at the allosteric site
- Adding a noncompetitive inhibitor to restore the original curve shape
- Increasing substrate concentration to favor the high-activity state despite the allosteric inhibitor (correct answer)
Explanation: This question tests understanding of allosteric regulation and how to overcome negative allosteric effects. The allosteric inhibitor Z shifts the curve rightward (increasing apparent Km) and makes it more sigmoidal without changing maximal velocity, indicating K-type (K-system) allosteric inhibition that affects substrate binding cooperativity. Since the maximal rate at very high substrate is unchanged, the enzyme can still achieve full activity when substrate concentration is sufficiently high to drive the equilibrium toward the high-activity state. This is analogous to how excess substrate can overcome competitive inhibition, but here it's overcoming the allosteric shift in binding affinity rather than direct competition. A common misconception is that decreasing substrate would help (choice B), but this would actually reduce enzyme activity further when an allosteric inhibitor favors the low-affinity state. To overcome K-type allosteric inhibition: (1) increase substrate concentration to saturate even the low-affinity form, and (2) remember that if Vmax is preserved, the enzyme's catalytic capability remains intact.
Question 20
An enzyme in fatty acid synthesis was assayed at fixed [enzyme] with varying substrate concentration. When an inhibitor Y was added, the Lineweaver–Burk plot showed the same x-intercept as control but a larger y-intercept. Which inhibitor mechanism is most consistent with this pattern?
- Competitive inhibition, because the x-intercept shifts toward zero
- Noncompetitive inhibition, because the y-intercept increases while the x-intercept is unchanged (correct answer)
- Uncompetitive inhibition, because both intercepts shift in parallel
- Allosteric activation, because 1/Vmax decreases
Explanation: This question tests interpretation of Lineweaver-Burk plots to identify inhibition mechanisms. In a Lineweaver-Burk plot (1/v vs 1/[S]), the y-intercept equals 1/Vmax and the x-intercept equals -1/Km. The data shows an unchanged x-intercept (same Km) but increased y-intercept (decreased Vmax), which is the diagnostic pattern for noncompetitive inhibition. This occurs because noncompetitive inhibitors reduce the effective enzyme concentration or catalytic efficiency without affecting substrate binding, so Km remains constant while Vmax decreases. A common error is confusing the intercept changes - competitive inhibition would change the x-intercept (Km) while keeping the y-intercept (Vmax) constant, which is the opposite of what's observed here. To interpret Lineweaver-Burk plots for inhibition type: (1) unchanged x-intercept with changed y-intercept indicates noncompetitive inhibition, and (2) remember that larger y-intercept means smaller Vmax (since it's 1/Vmax).